FDA Approves Gene Therapy for Children With Sickle Cell Disease

The U.S. Food and Drug Administration has approved a new gene therapy for children aged 2 and older with sickle cell disease. The approval offers fresh hope to young patients and families managing the painful, inherited blood disorder.